Shares of social media giant Facebook (NASDAQ FB) declined after the company got a rare downgrade from Janney Capital. Shares of Facebook were close to their all-time high, so a downgrade based on valuation concerns may not be too surprising to some. Janney Capital cut its rating on Facebook shares from Buy to Neutral. However, it is important to note that the analyst left his … Continue reading Stock Highlights: Facebook FB Stock Downgraded
Google Inc’s (NASDAQ GOOG) self-driving car may drive itself, but the conditions in which it can operate effectively are very limited. These observations come from an article in the MIT Technology Review. In some ways, the self-driving car is not self-driving at all. The research shows how easy it is for hype to get ahead of reality when new, widely watched products are launched. Included … Continue reading Stock Update: A Report on Google (NASDAQ GOOG) Self Driving Cars
It’s believed that Apple Inc (NASDAQ AAPL) will unveil the iWatch on Sept. 9 along with the iPhone 6. However, there have been rumors that the wearable device won’t be available until early next year. Some would think that this would be bad because Apple is getting in months after competitors’ latest models and more than a year after their first models. But on the … Continue reading Apple AAPL Stock News: A Look at iWatch
Microsoft Corporation (NASDAQ MSFT) announced that it would be implementing some of the features requested by Xbox One players to improve their gaming experiences. A new feature involves the mobile purchase feature which allows Xbox One players to purchase games and add-on content using the Xbox SmartGlass or through Xbox.com. According to the company, it will roll out the next Xbox One System update to … Continue reading Active Stock MSFT: Microsoft (NASDAQ MSFT) Updates Xbox
Biotech is back. This spring, biotech stocks collapsed. The Nasdaq Biotechnology Index tumbled 22% in about six weeks, inflicting huge losses on hedge funds and other investors, including holders of a popular exchange-traded fund known for its ticker “IBB,” the iShares Nasdaq Biotechnology ETF , which has about $5.5 billion in assets. So far in August, the Nasdaq Biotechnology Index is up 10%. That puts … Continue reading Biotech Stocks Back Up High : Analysis
Regado Biosciences, Inc (RGDO) announced that it is permanently terminating the enrollment process for its phase III REGULATE-PCI study on Revolixys Kit. Regado’s shares tumbled over 60% on the news. Regado was dealt a severe blow with the Data and Safety Monitoring Board for a late-stage study recommending the permanent termination of patient enrolment. The phase III study was a part of the company’s lead … Continue reading Biotech News: Regado Slumps Low Due to Poor Test Results
